The Psychedelic Therapeutics and Drug Development announced that PsychedelicNewsWire (“PNW), a specialized communications platform for the psychedelics sector and one of more than 60 brands powered by IBN (“InvestorBrandNetwork”), will be the official media sponsor for this month’s conference. The fourth annual Psychedelic Therapeutics and Drug Development Conference is scheduled for May 23–24, 2024, in Boston. Hosted by Arrowhead SciTech Conferences & Events, the conference is focused on research and development of psychedelics in the healthcare space. The conference agenda features presentations by the world’s leading researchers and thought leaders in academia, industry, the nonprofit sector and government, with an objective to bridge gaps in the research and development sphere related to therapeutic psychedelics for a variety of health conditions and unmet needs. According to the announcement, IBN and PNW will take advantage of the full suite of state-of-the-art communications tools to increase coverage for the event. “With the series entering its fourth year, we are pleased to have PsychedelicNewsNetwork acting as our media partner for our May 2024 event,” said Arrowhead SciTech Conferences & Events managing director John Waslif in the press release. “Having built a strong reputation for research and development events in the psychedelic-drug-development healthcare space, we believe that InvestorBrandNetwork and its affiliates are the ideal partners to drive recognition for our speakers, participating organizations, and the conference itself. IBN’s world-class communications outreach and services will play a key role in elevating the visibility of the event and driving home the importance of such collaborative efforts across target audiences. We look forward to working with their highly professional and energetic team.”
To view the full press release, visit https://ibn.fm/KUzeC
About the Psychedelic Therapeutics and Drug Development Conference
The fourth annual Psychedelic Therapeutics and Drug Development Conference is coming to Boston on May 23–24, 2024. This event has been organized to bring together the world’s leading researchers and leaders in academia, industry, the nonprofit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made toward regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid-use disorder. For more information about the conference, visit www.Psychedelics-Conference.com
About PsychedelicNewsWire
PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicNewsWire.com
PsychedelicNewsWire is powered by IBN
